120 related articles for article (PubMed ID: 11133087)
1. Substituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements.
Falardeau G; Chan L; Stefanac T; May S; Jin H; Lavallée JF
Bioorg Med Chem Lett; 2000 Dec; 10(24):2769-70. PubMed ID: 11133087
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors.
Chan L; Jin H; Stefanac T; Lavallée JF; Falardeau G; Wang W; Bédard J; May S; Yuen L
J Med Chem; 1999 Aug; 42(16):3023-5. PubMed ID: 10447945
[No Abstract] [Full Text] [Related]
3. Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.
Falardeau G; Lachance H; St-Pierre A; Yannopoulos CG; Drouin M; Bédard J; Chan L
Bioorg Med Chem Lett; 2005 Mar; 15(6):1693-5. PubMed ID: 15745823
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines.
Chan L; Stefanac T; Lavallée JF; Jin H; Bédard J; May S; Falardeau G
Bioorg Med Chem Lett; 2001 Jan; 11(2):103-5. PubMed ID: 11206437
[TBL] [Abstract][Full Text] [Related]
5. Isoquinoline-6-carboxamides as potent and selective anti-human cytomegalovirus (HCMV) inhibitors.
Chan L; Jin H; Stefanac T; Wang W; Lavallée JF; Bédard J; May S
Bioorg Med Chem Lett; 1999 Sep; 9(17):2583-6. PubMed ID: 10498213
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors.
Chan L; Stefanac T; Turcotte N; Hu Z; Chen Y; Bédard J; May S; Jin H
Bioorg Med Chem Lett; 2000 Jul; 10(13):1477-80. PubMed ID: 10888336
[TBL] [Abstract][Full Text] [Related]
7. Naphthyridines with Antiviral Activity - A Review.
Singh IP; Kumar S; Gupta S
Med Chem; 2017; 13(5):430-438. PubMed ID: 28031019
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
[TBL] [Abstract][Full Text] [Related]
9. SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series.
Bernardino AM; Castro HC; Frugulhetti IC; Loureiro NI; Azevedo AR; Pinheiro LC; Souza TM; Giongo V; Passamani F; Magalhães UO; Albuquerque MG; Cabral LM; Rodrigues CR
Bioorg Med Chem; 2008 Jan; 16(1):313-21. PubMed ID: 17937990
[TBL] [Abstract][Full Text] [Related]
10. Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity.
Martinez A; Gil C; Castro A; Pérez C; Prieto C; Otero J
Bioorg Med Chem; 2003 May; 11(11):2395-402. PubMed ID: 12735985
[TBL] [Abstract][Full Text] [Related]
11. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives.
Martinez A; Gil C; Castro A; Bruno AM; Pérez C; Prieto C; Otero J
Antivir Chem Chemother; 2003 Mar; 14(2):107-14. PubMed ID: 12856922
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent.
Hao T; Li Y; Fan S; Li W; Wang S; Li S; Cao R; Zhong W
Eur J Med Chem; 2019 Aug; 175():172-186. PubMed ID: 31082764
[TBL] [Abstract][Full Text] [Related]
13. Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.
Zeng LF; Wang Y; Kazemi R; Xu S; Xu ZL; Sanchez TW; Yang LM; Debnath B; Odde S; Xie H; Zheng YT; Ding J; Neamati N; Long YQ
J Med Chem; 2012 Nov; 55(22):9492-509. PubMed ID: 23098137
[TBL] [Abstract][Full Text] [Related]
14. Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus.
Mavel S; Renou JL; Galtier C; Allouchi H; Snoeck R; Andrei G; De Clercq E; Balzarini J; Gueiffier A
Bioorg Med Chem; 2002 Apr; 10(4):941-6. PubMed ID: 11836102
[TBL] [Abstract][Full Text] [Related]
15. Thiourea inhibitors of herpes viruses. Part 1: bis-(aryl)thiourea inhibitors of CMV.
Bloom JD; DiGrandi MJ; Dushin RG; Curran KJ; Ross AA; Norton EB; Terefenko E; Jones TR; Feld B; Lang SA
Bioorg Med Chem Lett; 2003 Sep; 13(17):2929-32. PubMed ID: 14611860
[TBL] [Abstract][Full Text] [Related]
16. Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.
Kim KH; Wissner A; Floyd MB; Fraser HL; Wang YD; Dushin RG; Hu Y; Olland A; Guo B; Arndt K
Bioorg Med Chem Lett; 2009 Sep; 19(17):5225-8. PubMed ID: 19628388
[TBL] [Abstract][Full Text] [Related]
17. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors.
Bauer U; Giordanetto F; Bauer M; O'Mahony G; Johansson KE; Knecht W; Hartleib-Geschwindner J; Carlsson ET; Enroth C
Bioorg Med Chem Lett; 2012 Mar; 22(5):1944-8. PubMed ID: 22321214
[TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
Jung E; Majima R; Edwards TC; Soto-Acosta R; Geraghty RJ; Wang Z
ChemMedChem; 2022 Sep; 17(17):e202200334. PubMed ID: 35879245
[TBL] [Abstract][Full Text] [Related]
20. 1,8-naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities.
Mithula S; Nandikolla A; Murugesan S; Kondapalli VG
Future Med Chem; 2021 Sep; 13(18):1591-1618. PubMed ID: 34256591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
